Verona Pharma plc - Company & Market Research Reports

Verona Pharma is a biopharmaceutical company that aims to improve the lives of those suffering from respiratory diseases by innovating therapeutic products. It was founded in 2005 in London, England. There proprietary lead candidate, RPL554 has opened a door to a whole new generation of drugs as it combines bronchodilator and an anti-inflammatory agent in a single compound. It has the potential to provide relief for the many patients suffering from respiratory conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and possibly asthma. Verona Pharma is listed on the NASDAQ global market and is supported by investors from U.S, U.K and Europe.

Global Bronchodilators Market 2017-2021 - Product Thumbnail Image

Global Bronchodilators Market 2017-2021

  • Report
  • 83 Pages
From
Allergic Asthma - Pipeline Review, H2 2016 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H2 2016

  • Report
  • 181 Pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2018 - Product Thumbnail Image

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2018

  • Report
  • 238 Pages
From
Allergic Asthma - Pipeline Review, H1 2016 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H1 2016

  • Report
  • 182 Pages
From
Allergic Asthma - Pipeline Review, H2 2015 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H2 2015

  • Report
  • 146 Pages
From
Allergic Asthma - Pipeline Review, H1 2015 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H1 2015

  • Report
  • 142 Pages
From
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 1406 Pages
From
Asthma: Pipeline Assessment and Insights - Product Thumbnail Image

Asthma: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Asthma: Market Intelligence Review and Insights - Product Thumbnail Image

Asthma: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Global Allergy Immunotherapy Market Analysis & Trends - Product Type , Application - Forecast to 2025 - Product Thumbnail Image

Global Allergy Immunotherapy Market Analysis & Trends - Product Type , Application - Forecast to 2025

  • Report
  • 170 Pages
From
Global Asthma Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Asthma Therapeutics Market 2016-2020

  • Report
  • 110 Pages
From
Asthma - Pipeline Review, H1 2018 - Product Thumbnail Image

Asthma - Pipeline Review, H1 2018

  • Report
  • 592 Pages
From
COPD: Epidemiology Overview and Insights - Product Thumbnail Image

COPD: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
COPD: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

COPD: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020 - Product Thumbnail Image

Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020

  • Report
  • 107 Pages
From
COPD Drugs Market in China 2016-2020 - Product Thumbnail Image

COPD Drugs Market in China 2016-2020

  • Report
  • 74 Pages
From
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2018

  • Report
  • 529 Pages
From
Cystic Fibrosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H1 2018

  • Report
  • 412 Pages
From
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) -Pipeline Insight, 2018 - Product Thumbnail Image

Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Loading Indicator
adroll